349 related articles for article (PubMed ID: 33790556)
1. Enhancing Cancer Immunotherapy Treatment Goals by Using Nanoparticle Delivery System.
Muluh TA; Chen Z; Li Y; Xiong K; Jin J; Fu S; Wu J
Int J Nanomedicine; 2021; 16():2389-2404. PubMed ID: 33790556
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticles for tumor immunotherapy.
Zang X; Zhao X; Hu H; Qiao M; Deng Y; Chen D
Eur J Pharm Biopharm; 2017 Jun; 115():243-256. PubMed ID: 28323111
[TBL] [Abstract][Full Text] [Related]
3. Delivery strategies of cancer immunotherapy: recent advances and future perspectives.
Zhao Z; Zheng L; Chen W; Weng W; Song J; Ji J
J Hematol Oncol; 2019 Nov; 12(1):126. PubMed ID: 31779642
[TBL] [Abstract][Full Text] [Related]
4. Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy.
Lim S; Park J; Shim MK; Um W; Yoon HY; Ryu JH; Lim DK; Kim K
Theranostics; 2019; 9(25):7906-7923. PubMed ID: 31695807
[TBL] [Abstract][Full Text] [Related]
5. Engineering nanoparticle strategies for effective cancer immunotherapy.
Yoon HY; Selvan ST; Yang Y; Kim MJ; Yi DK; Kwon IC; Kim K
Biomaterials; 2018 Sep; 178():597-607. PubMed ID: 29576282
[TBL] [Abstract][Full Text] [Related]
6. Targeting myeloid cells using nanoparticles to improve cancer immunotherapy.
Amoozgar Z; Goldberg MS
Adv Drug Deliv Rev; 2015 Aug; 91():38-51. PubMed ID: 25280471
[TBL] [Abstract][Full Text] [Related]
7. Nanotechnology in the arena of cancer immunotherapy.
Asadujjaman M; Cho KH; Jang DJ; Kim JE; Jee JP
Arch Pharm Res; 2020 Jan; 43(1):58-79. PubMed ID: 31956965
[TBL] [Abstract][Full Text] [Related]
8. Optimizing Advances in Nanoparticle Delivery for Cancer Immunotherapy.
Caster JM; Callaghan C; Seyedin SN; Henderson K; Sun B; Wang AZ
Adv Drug Deliv Rev; 2019 Apr; 144():3-15. PubMed ID: 31330165
[TBL] [Abstract][Full Text] [Related]
9. Gold nanoparticle mediated cancer immunotherapy.
Almeida JP; Figueroa ER; Drezek RA
Nanomedicine; 2014 Apr; 10(3):503-14. PubMed ID: 24103304
[TBL] [Abstract][Full Text] [Related]
10. Tumor immune microenvironment modulation-based drug delivery strategies for cancer immunotherapy.
Han S; Huang K; Gu Z; Wu J
Nanoscale; 2020 Jan; 12(2):413-436. PubMed ID: 31829394
[TBL] [Abstract][Full Text] [Related]
11. Nanotechnology platforms for cancer immunotherapy.
Yang Z; Ma Y; Zhao H; Yuan Y; Kim BYS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1590. PubMed ID: 31696664
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-Mediated Remodeling of the Tumor Microenvironment to Enhance Immunotherapy.
Musetti S; Huang L
ACS Nano; 2018 Dec; 12(12):11740-11755. PubMed ID: 30508378
[TBL] [Abstract][Full Text] [Related]
13. Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy.
Huang P; Wang X; Liang X; Yang J; Zhang C; Kong D; Wang W
Acta Biomater; 2019 Feb; 85():1-26. PubMed ID: 30579043
[TBL] [Abstract][Full Text] [Related]
14. The use of nanoparticles as a promising therapeutic approach in cancer immunotherapy.
Hosseini M; Haji-Fatahaliha M; Jadidi-Niaragh F; Majidi J; Yousefi M
Artif Cells Nanomed Biotechnol; 2016 Jun; 44(4):1051-61. PubMed ID: 25612903
[TBL] [Abstract][Full Text] [Related]
15. Delivery technologies for cancer immunotherapy.
Riley RS; June CH; Langer R; Mitchell MJ
Nat Rev Drug Discov; 2019 Mar; 18(3):175-196. PubMed ID: 30622344
[TBL] [Abstract][Full Text] [Related]
16. Cancer Nano-Immunotherapy from the Injection to the Target: The Role of Protein Corona.
Mikelez-Alonso I; Aires A; Cortajarena AL
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947622
[TBL] [Abstract][Full Text] [Related]
17. Cell membrane coated nanoparticles as a biomimetic drug delivery platform for enhancing cancer immunotherapy.
Zhong Z; Deng W; Wu J; Shang H; Tong Y; He Y; Huang Q; Ba X; Chen Z; Tang K
Nanoscale; 2024 May; 16(18):8708-8738. PubMed ID: 38634521
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles in cancer immunotherapies: An innovative strategy.
Nasirmoghadas P; Mousakhani A; Behzad F; Beheshtkhoo N; Hassanzadeh A; Nikoo M; Mehrabi M; Kouhbanani MAJ
Biotechnol Prog; 2021 Mar; 37(2):e3070. PubMed ID: 32829506
[TBL] [Abstract][Full Text] [Related]
19. A novel Granzyme B nanoparticle delivery system simulates immune cell functions for suppression of solid tumors.
Qian X; Shi Z; Qi H; Zhao M; Huang K; Han D; Zhou J; Liu C; Liu Y; Lu Y; Yuan X; Zhao J; Kang C
Theranostics; 2019; 9(25):7616-7627. PubMed ID: 31695790
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticulate immunotherapy for cancer.
Kapadia CH; Perry JL; Tian S; Luft JC; DeSimone JM
J Control Release; 2015 Dec; 219():167-180. PubMed ID: 26432555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
